Global Hospital Acquired Infection Control Market : Segments, Dynamics, Size and Forecast to 2020

Transcription

Global Hospital Acquired Infection Control Market : Segments, Dynamics, Size and Forecast to 2020
Global Hospital Acquired Infection Control Market :
Forecast 2014 - 2020
Persistence Market Research
Global HAIs (Hospital-Acquired Infections)
Control Market will grow $82,889.4 million in
2020 - Persistence Market Research
Persistence Market Research
1
Global Hospital Acquired Infection Control Market :
Forecast 2014 - 2020
Persistence Market Research Released New Market Report “Global Hospital Acquired Infection
Control Market : Forecast 2014 - 2020”, the global HAIs control market was valued at USD 50,807.0
million in 2014 and is expected to grow at a CAGR of 8.5% from 2014 to 2020, to reach an estimated
value of USD 82,889.4 million in 2020..
HAIs or nosocomial infections refer to infections that are usually contracted during prolonged hospital
stays. These infections are caused by the transmission of pathogens from one patient to another or from
a healthcare worker to a patient. Causes of HAIs include lack of proper hospital infrastructure, lack of
awareness about pathogen transmission among the hospital staff due to lack of training and poor
infection control practices in hospitals. In addition, inadequate facilities and insufficient access to
techniques for maintaining hygienic conditions in hospitals also lead to HAIs.
Interested in report: Please follow the below links to meet your requirements; Request for the
Report Sample: http://www.persistencemarketresearch.com/samples/2814
Globally, the HAIs control market is witnessing significant growth due to rising aging population and
increasing incidence of various HAIs. In addition, hot and humid climatic conditions in some regions and
increasing initiatives undertaken by various government associations spreading awareness about
prevention and control of HAIs are driving the HAIs control market. However, lack of primary healthcare
facilities and infrastructure such as lack of proper buildings, supplies, medical and communication
equipment have a restraining impact on the global market for HAIs control. In addition, untrained staff and
lack of awareness in some developing regions have a negative impact on the growth of global HAIs
market. The global HAIs control market is estimated at USD 50,807.0 million in 2014 and expected to
reach USD 82,889.4 million in 2020, growing at a CAGR of 8.5%.
View TOC (table of content), Figures and Tables of the Report:
http://www.persistencemarketresearch.com/toc/2814
North America has the largest market for the global HAIs control market. This is due to improved
healthcare facilities in the region. North American market for HAIs control is estimated at USD 21,319.2
million in 2014 and is expected to reach USD 34,430.3 million in 2020, growing at a CAGR of 8.3%. Asia
is the fastest growing region; this is due to increasing prevalence of HAIs cases in the region. In terms of
Persistence Market Research
2
Global Hospital Acquired Infection Control Market :
Forecast 2014 - 2020
type, cleaning and sterilization is the fastest growing segment. In terms of diseases, market for the
treatment of primary bloodstream infections is the fastest growing.
For more info: http://www.persistencemarketresearch.com/contact-us.asp
Some of the latest trends that have been observed in the global HAIs control market include increasing
popularity of gas plasma sterilization technology. STERIS Corporation, followed by Getinge AB is a
leading player in the global market for HAIs control. Some of the other major players in HAIs control
market are Pfizer, Inc., Advanced Sterilization Products Division Ethicon US, LLC, Becton, Dickinson and
Company and Hoffmann-La Roche, Ltd.
The HAIs control market is segmented as follows:
HAIs Control Market, By Type
•
Cleaning and Sterilization
•
Diagnostic Techniques
•
Treatment
HAIs Control Market, By Cleaning and Sterilization
•
Instrument Sterilization
•
Wide-Area Sterilization
•
Disinfection of Linen
HAIs Control Market, By Diagnostic Techniques
•
Manual Testing
•
Automated Testing
•
Confirmation Testing
Persistence Market Research
3
Global Hospital Acquired Infection Control Market :
Forecast 2014 - 2020
HAIs Control Market, By Treatment
•
Pharmaceutical Treatment
•
Environmental Treatment
HAIs Control Market, By Pharmaceutical Treatment
•
Viral HAI Pharmaceuticals
•
Bacterial HAI Pharmaceuticals
•
Fungal HAI Pharmaceuticals
HAIs Control Market, By Environmental Treatment
•
Air Treatment
•
Water Treatment
•
Chemical Treatment
HAIs Control Market, by Geography
North America
•
U.S.
•
Rest of North America
Europe
•
Germany
•
U.K.
•
France
Rest of Europe
•
Asia
•
Japan
•
China
Persistence Market Research
4
Global Hospital Acquired Infection Control Market :
Forecast 2014 - 2020
Market History:
Hospital-acquired infections (HAIs), also known as nosocomial infections, refer to infections that are
acquired by patients during their stay in hospitals. Globally, the HAIs control market is witnessing
significant growth due to high prevalence of various hospital infections and increasing aging population. In
addition, rising number of initiatives undertaken by government and nongovernment organizations and hot
and humid environmental conditions are driving the HAIs control market. However, factors such as lack of
primary healthcare facilities and infrastructure and limited awareness about HAIs in developing regions
are restraining the global market for HAIs control. Increasing popularity of gas plasma sterilization
technology is one of the major trends that have been observed in the HAIs control market. The global
HAIs control market is estimated at USD 50,807.0 million in 2014. It is likely to grow with a CAGR of 8.5%
and reach USD 82,889.4 million in 2020.
North America has the largest market for the HAIs control market. North America market for HAIs control
is estimated at USD 21,319.2 million in 2014 and is expected to reach USD 34,430.3 million in 2020,
growing at a CAGR of 8.3%. Diagnostic techniques are the largest segment in the overall HAIs control
market. In terms of diseases, pneumonia is the largest segment. In terms of growth, Asia is the fastest
growing region, cleaning and sterilization is the fastest growing segment and primary bloodstream
infections are the fastest growing type of HAIs.
STERIS Corporation is a leading player for cleaning and sterilization in the overall HAIs control market,
with a share of about 25% of the cleaning and sterilization market in 2013. Getinge AB accounts for about
24% of the global cleaning and sterilization market for HAIs control. Some of the other major players in
HAIs control market are Advanced Sterilization Products Division Ethicon US, LLC, Cepheid, Pfizer, Inc,
Hoffmann-La Roche, Ltd., Becton, Dickinson and Company and Kimberly-Clark Corporation.
Persistence Market Research
5
Global Hospital Acquired Infection Control Market :
Forecast 2014 - 2020
Persistence Market Research
6
Global Hospital Acquired Infection Control Market :
Forecast 2014 - 2020
Table of Content
Chapter 1 Preface
1.1 Report Description
1.2 Research Methodology
1.3 Assumptions
Chapter 2 Market Synopsis
Chapter 3 Porter’s Five Forces Analysis
3.1 Bargaining Power of Suppliers
3.2 Bargaining Power of Buyers
3.3 Threat of New Entrants
3.4 Threat of Substitutes
3.5 Intensity of Rivalry
Chapter 4 Market Overview
4.1 Market Definition
4.2 Market Drivers
4.2.1 High prevalence of various hospital infections
4.2.2 Increasing aging population
4.2.3 Rising number of initiatives undertaken by government and nongovernment organizations
4.2.4 Hot and humid environmental conditions
4.3 Impact Analysis of Market Drivers
4.4 Market Restrains
4.4.1 Lack of primary healthcare facilities and infrastructure
4.4.2 Limited awareness about HAIs in developing regions
4.5 Impact Analysis of Market Restrains
4.6 Market Trends
4.6.1 Increasing popularity of gas plasma sterilization technology
4.6.2 Companies focusing on new product launches
4.6.3 Increasing number of mergers and acquisitions
4.7 Market Challenges
4.7.1 Rising number of multi-drug-resistant microbial pathogens
Persistence Market Research
7
Global Hospital Acquired Infection Control Market :
Forecast 2014 - 2020
Chapter 5 Global Market Size and Forecast
5.1 On the Basis of Geography
5.2 On the Basis of Type
5.3 On the Basis of Diseases
Chapter 6 Market Size and Forecast by Cleaning and Sterilization
6.1 By Region
6.2 By Type
6.2.1 Instrument sterilization
6.2.2 Wide-area sterilization
6.2.3 Disinfection of linen
Chapter 7 Market Size and Forecast by Diagnostic Techniques
7.1 By Region
7.2 By Type
7.2.1 Manual testing
7.2.2 Automated testing
7.2.3 Confirmation testing
Chapter 8 Market Size and Forecast by Treatment
8.1 By Region
8.2 By Type
8.2.1 Pharmaceutical treatment
8.2.2 Environmental treatment
8.3 By Type of Pharmaceutical Treatment
8.3.1 Viral HAI pharmaceuticals
8.3.2 Bacterial HAI pharmaceuticals
8.3.3 Fungal HAI pharmaceuticals
8.4 By Type of Environmental Treatment
8.4.1 Air treatment
8.4.2 Water treatment
8.4.3 Chemical treatment
Persistence Market Research
8
Global Hospital Acquired Infection Control Market :
Forecast 2014 - 2020
Chapter 9 Market Size and Forecast by Disease
9.1 Pneumonia
9.2 Gastrointestinal Illnesses
9.3 Urinary Tract Infections (UTI)
9.4 Surgical Site Infections
9.5 Primary Bloodstream Infections
Chapter 10 Market Size and Forecast by Geography
10.1 North America
10.2 Europe
10.3 Asia
Chapter 11 Competitive Scenario
11.1 Competitive Benchmarking
11.2 Company Share Analysis
Chapter 12 Company Profiles
12.1 Advanced Sterilization Products Division Ethicon US, LLC
12.1.1 Company overview
12.1.2 Products and services
12.1.3 Financial performance
12.1.4 Key developments
12.2 STERIS Corporation
12.2.1 Company overview
12.2.2 Product and segments
12.2.3 Financial performance
12.2.4 Key developments
12.3 Cepheid
12.3.1 Company overview
12.3.2 Products and services
12.3.3 Financial performance
12.3.4 Key developments
12.4 Cantel Medical
12.4.1 Company overview
12.4.2 Products and services
Persistence Market Research
9
Global Hospital Acquired Infection Control Market :
Forecast 2014 - 2020
12.4.3 Financial performance
12.4.4 Key developments
12.5 Getinge AB
12.5.1 Company overview
12.5.2 Products and services
12.5.3 Financial performance
12.5.4 Key developments
12.6 Pfizer, Inc.
12.6.1 Company overview
12.6.2 Products and services
12.6.3 Financial performance
12.6.4 Key developments
12.7 Merck & Co., Inc.
12.7.1 Company overview
12.7.2 Products and services
12.7.3 Financial performance
12.7.4 Key developments
12.8 Hoffmann-La Roche, Ltd.
12.8.1 Company overview
12.8.2 Products and services
12.8.3 Financial performance
12.8.4 Key developments
12.9 Becton, Dickinson and Company
12.9.1 Company overview
12.9.2 Products and services
12.9.3 Financial performance
12.9.4 Key developments
12.10 Kimberly-Clark Corporation
12.10.1 Company overview
12.10.2 Products and services
12.10.3 Financial performance
12.10.4 Key developments
12.11 bioMerieux SA
12.11.1 Company overview
12.11.2 Products and services
Persistence Market Research
10
Global Hospital Acquired Infection Control Market :
Forecast 2014 - 2020
12.11.3 Financial performance
12.11.4 Key developments
List of Tables
TABLE 1 Market snapshot: Global market of HAIs control (2014 and 2020)
TABLE 2 Drivers for global HAIs control market: Impact analysis
TABLE 3 Restrains for global HAIs control market: Impact analysis
TABLE 4 Products launched by various companies
TABLE 5 Some mergers and acquisitions in HAIs control market
TABLE 6 Global HAIs control market size, by region, 2010 – 2013 (USD million)
TABLE 7 Global HAIs control market size, by region, 2014 – 2020 (USD million)
TABLE 8 Global HAIs control market size, by type, 2010 – 2013 (USD million)
TABLE 9 Global HAIs control market size, by type, 2014 – 2020 (USD million)
TABLE 10 Global HAIs control market size, by disease, 2010 – 2013 (USD million)
TABLE 11 Global HAIs control market size, by disease, 2014 – 2020 (USD million)
TABLE 12 Global cleaning and sterilization market size, by region, 2010 – 2013 (USD million)
TABLE 13 Global cleaning and sterilization market size, by region, 2014 – 2020 (USD million)
TABLE 14 Global cleaning and sterilization market size, by type, 2010 – 2013 (USD million)
TABLE 15 Global cleaning and sterilization market size, by type, 2014 – 2020 (USD million)
TABLE 16 Global diagnostic techniques market size, by region, 2010 – 2013 (USD million)
TABLE 17 Global diagnostic techniques market size, by region, 2014 – 2020 (USD million)
TABLE 18 Global diagnostic techniques market size, by type, 2010 – 2013 (USD million)
TABLE 19 Global diagnostic techniques market size, by type, 2014 – 2020 (USD million)
TABLE 20 Global HAIs treatment market size, by region, 2010 – 2013 (USD million)
TABLE 21 Global HAIs treatment market size, by region, 2014 – 2020 (USD million)
TABLE 22 Global HAIs treatment market size, by type, 2010 – 2013 (USD million)
TABLE 23 Global HAIs treatment market size, by type, 2014 – 2020 (USD million)
TABLE 24 Global pharmaceutical treatment market size, by type, 2010 – 2013 (USD million)
TABLE 25 Global pharmaceutical treatment market size, by type, 2014 – 2020 (USD million)
TABLE 26 Global environmental treatment market size, by type, 2010 – 2013 (USD million)
TABLE 27 Global environmental treatment market size, by type, 2014 – 2020 (USD million)
TABLE 28 Global pneumonia treatment market size, by region, 2010 – 2013 (USD million)
TABLE 29 Global pneumonia treatment market size, by region, 2014 – 2020 (USD million)
TABLE 30 Global gastrointestinal illnesses treatment market size, by region, 2010 – 2013 (USD million)
Persistence Market Research
11
Global Hospital Acquired Infection Control Market :
Forecast 2014 - 2020
TABLE 31 Global gastrointestinal illnesses treatment market size, by region, 2014 – 2020 (USD million)
TABLE 32 Global urinary tract infections treatment market size, by region, 2010 – 2013 (USD million)
TABLE 33 Global urinary tract infections treatment market size, by region, 2014 – 2020 (USD million)
TABLE 34 Global surgical site infections treatment market size, by region, 2010 – 2013 (USD million)
TABLE 35 Global surgical site infections treatment market size, by region, 2014 – 2020 (USD million)
TABLE 36 Global primary bloodstream infections treatment market size, by region, 2010 – 2013 (USD
million)
TABLE 37 Global primary bloodstream infections treatment market size, by region, 2014 – 2020 (USD
million)
TABLE 38 North American HAIs control market size, by country, 2010 – 2013 (USD million)
TABLE 39 North American HAIs control market size, by country, 2014 – 2020 (USD million)
TABLE 40 European HAIs control market size, by country, 2010 – 2013 (USD million)
TABLE 41 European HAIs control market size, by country, 2014 – 2020 (USD million)
TABLE 42 Asian HAIs control market size, by country, 2010 – 2013 (USD million)
TABLE 43 Asian HAIs control market size, by country, 2014 – 2020 (USD million)
TABLE 44 Major product categories of Advanced Sterilization Products
TABLE 45 Major products categories of STERIS Corporation
TABLE 46 Major product categories of Cepheid
TABLE 47 Major product categories of Cantel Medical
TABLE 48 Major product categories of Getinge AB’s Infection Control business
TABLE 49 Major product categories of Pfizer, Inc.
TABLE 50 Major product categories of Merck & Co., Inc.
TABLE 51 Major product categories of Roche
TABLE 52 Major product categories of Becton, Dickinson and Company
TABLE 53 Major product categories of Kimberly-Clark Corporation
TABLE 54 Major product categories of bioMerieux SA
Persistence Market Research
12
Global Hospital Acquired Infection Control Market :
Forecast 2014 - 2020
List of Figures
FIG. 1 HAI control market: Porter’s five force analysis
FIG. 2 Types of hospital-acquired infections
FIG. 3 Aging population in major countries, 2000 – 2050 (% share in total population)
FIG. 4 Global HAIs control market share, by region, by value, 2013
FIG. 5 Global HAIs control market share, by type, by value, 2013
FIG. 6 Global HAIs control market share, by disease, by value, 2013
FIG. 7 Global cleaning and sterilization market share, by region, by value, 2013
FIG. 8 Global cleaning and sterilization market share, by type, by value, 2013
FIG. 9 Global diagnostic techniques market share, by region, by value, 2013
FIG. 10 Global diagnostic techniques market share, by type, by value, 2013
FIG. 11 Global HAIs treatment market share, by region, by value, 2013
FIG. 12 Global HAIs treatment market share, by type, by value, 2013
FIG. 13 Global pharmaceutical treatment market share, by type, by value, 2013
FIG. 14 Global environment treatment market share, by type, by value, 2013
FIG. 15 Global pneumonia treatment market share, by region, by value, 2013
FIG. 16 Global gastrointestinal illness treatment market share, by region, by value, 2013
FIG. 17 Global urinary tract infections treatment market share, by region, by value, 2013
FIG. 18 Global surgical site infections treatment market share, by region, by value, 2013
FIG. 19 Global primary bloodstream infections treatment market share, by region, by value, 2013
FIG. 20 North American HAIs control market share, by country, by value, 2013
FIG. 21 European HAIs control market share, by country, by value, 2013
FIG. 22 Asian HAIs control market share, by country, by value, 2013
FIG. 23 Competitive landscape of HAIs control products providers, 2013
FIG. 24 Global Cleaning and Sterilization Market, by Company, 2013 (% Share)
FIG. 25 Steris Corporation’s revenue and net income, 2012 – 2014 (USD million)
FIG. 26 Cepheid’s sales and net income/ loss, 2011 – 2013 (USD million)
FIG. 27 Cantel Medical’s net sales and net income, 2011 – 2013 (USD million)
FIG. 28 Getinge ’s net sales and net profit, 2011 – 2013 (USD million)
FIG. 29 Pfizer, Inc.’s revenue and net income, 2011 – 2013 (USD million)
FIG. 30 Merck & Co., Inc.’s sales and net income, 2011 – 2013 (USD million)
FIG. 31 Roche’s sales and net income, 2011 – 2013 (USD million)
FIG. 32 Becton, Dickinson and Company’s revenue and income, 2012 – 2014 (USD million)
FIG. 33 Kimberly-Clark Corporation’s net sales and net income, 2011 – 2013 (USD million)
FIG. 34 BioMerieux SA’s net sales and net income, 2011 – 2013 (USD million)
Persistence Market Research
13
Global Hospital Acquired Infection Control Market :
Forecast 2014 - 2020
About Us:
Persistence Market Research (PMR) is a full-service market intelligence firm specializing in syndicated
research, custom research, and consulting services. PMR boasts market research expertise across the
Healthcare, Chemicals and Materials, Technology and Media, Energy and Mining, Food and Beverages,
Semiconductor and Electronics, Consumer Goods, and Shipping and Transportation industries. The
company draws from its multi-disciplinary capabilities and high-pedigree team of analysts to share data
that precisely corresponds to clients’ business needs.
PMR stands committed to bringing more accuracy and speed to clients’ business decisions. From readyto-purchase market research reports to customized research solutions, PMR’s engagement models are
highly flexible without compromising on its deep-seated research values.
Contact Us:
Persistence Market Research
305 Broadway
7th Floor, New York City,
NY 10007, United States,
USA - Canada Toll Free: 800-961-0353
Email: [email protected]
Web: http://www.persistencemarketresearch.com
Persistence Market Research
14